A computer generated rendering of a virus cell

PhRMA Member Company Efforts to Beat COVID-19

Return to the Industry’s latest efforts to beat COVID-19

Making Strides to Beat the Coronavirus

America’s biopharmaceutical companies have come together to push the boundaries of science and beat COVID-19. For decades, we’ve invested in new technology, research and development, and catalogued discovery, allowing us to quickly progress into trials for treatments and vaccines. We are already seeing scientific success with new and repurposed treatments and preventative vaccines showing promising results.

Together, we stand committed to treat and defend against disease in all its forms, not just COVID-19.

Read the Latest from PhRMA Member Companies

Member’s Snapshot

Below is a snapshot of ongoing PhRMA member company efforts to support the detection, prevention and treatment of the coronavirus outbreak. You may filter this information by company and/or commitment type using the search tool below. These filters are to help you refine your results and learn about the many ways our members are engaged in the fight against COVID-19.

Learn more about our efforts to combat coronavirus